Yttrium-90-labelled somatostatin-analogue for cancer treatment
- 1 February 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 351 (9100) , 417-418
- https://doi.org/10.1016/s0140-6736(05)78355-0
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA 0 , d -Phe 1 ,Tyr 3 ]octreotide, a promising somatostatin analogue for radionuclide therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- OctreotideNew England Journal of Medicine, 1996
- Somatostatin Receptor: Scintigraphy and Radionuclide TherapyDigestion, 1996